Georgetown University

In a first-of-its-kind study, researchers pitted mindfulness meditation against a common antidepressant in a trial on patients with anxiety. The findings reveal an eight-week mindfulness program was as effective at reducing anxiety as drug treatment.

Encouraging results from a small Phase 2 human trial testing the effects of a cancer drug in treating Alzheimer’s disease suggest the drug is safe, well-tolerated and alters biomarkers associated with Alzheimer’s. A larger study is currently planned.

Medical researchers have developed a blood test which predicts with 90 percent accuracy if an individual will develop Alzheimer's disease or mild cognitive impairment (MCI) within three years.